27.01.2014
- Indian drugmaker Ranbaxy Laboratories faces long delays and high costs in launching big-selling generic drugs in the U.S. after products from a fourth plant were banned due to...
14.09.2010
- A Challenging Business - The medicines supplied to patients are the final result of a very lengthy process (commonly about 10 years) and a huge investment both in monetary terms...
